243 results on '"Brouwers, Adrienne H."'
Search Results
2. Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)
3. Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy
4. Convolutional neural networks for automatic image quality control and EARL compliance of PET images
5. Shortened duration whole body 18F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function
6. Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CT
7. Advances and challenges in immunoPET methodology.
8. Use of population input functions for reduced scan duration whole-body Patlak 18F-FDG PET imaging
9. The effects of molar activity on [18F]FDOPA uptake in patients with neuroendocrine tumors
10. Current and Future Use of Long Axial Field-of-View Positron Emission Tomography/Computed Tomography Scanners in Clinical Oncology
11. Correlation between Histopathological Prognostic Tumor Characteristics and [ 18 F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.
12. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for89Zr-Trastuzumab
13. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
14. Abstract 5611: LAG-3 PET imaging in patients with cancer before immune checkpoint inhibitor therapy
15. The Diagnostic Value of 18F-FDG PET/CT Scan in Characterizing Adrenal Tumors
16. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab.
17. Clinical irrelevance of lower titer thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma
18. Optimization of parathyroid 11C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism
19. Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative 18F-FDG PET/CT analysis
20. [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma
21. Patient-derived parathyroid organoids as a tracer and drug-screening application model
22. Molecular imaging to support cancer immunotherapy
23. Volume of interest delineation techniques for 18F-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study
24. 89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer
25. Additional file 1 of Shortened duration whole body 18F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function
26. Additional file 1 of Convolutional neural networks for automatic image quality control and EARL compliance of PET images
27. Tailored imaging of islet cell tumors of the pancreas amidst increasing options
28. Low-Iodine Diet of 4 Days Is Sufficient Preparation for 131I Therapy in Differentiated Thyroid Cancer Patients
29. Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study
30. Shortened duration whole body 18F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function.
31. 89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
32. Bone Marrow Function After 131I Therapy in Patients With Differentiated Thyroid Carcinoma
33. First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti–PD-L1 Probody
34. Abstract LB037: 89ZED88082A PET imaging to visualize CD8+ T cells in patients with cancer treated with immune checkpoint inhibitor
35. Whole-body CD8+T cell visualization before and during cancer immunotherapy: a phase 1/2 trial
36. DekkerSupplementaldata.docx
37. Progressive Diastolic Dysfunction in Survivors of Pediatric DTC - Supplemental Data
38. Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy.
39. The Value of Pre-Ablative I-131 Scan for Clinical Management in Patients With Differentiated Thyroid Carcinoma
40. 18F-FDG PET/CT Scans Can Identify Sub-Groups of NSCLC Patients with High Glucose Uptake in the Majority of Their Tumor Lesions
41. Non‐adherence to consensus guidelines on preoperative imaging in surgery for primary hyperparathyroidism
42. Low-Iodine Diet of 4 Days Is Sufficient Preparation for 131I Therapy in Differentiated Thyroid Cancer Patients.
43. Assessment of Bone Lesions with18F-FDG PET Compared with99mTc Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management
44. PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability
45. Molecular imaging biomarkers for immune checkpoint inhibitor therapy
46. 6-[F-18]Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess
47. Localization of an Adrenocorticotropin-Producing Pheochromocytoma Using 18F-Dihydroxyphenylalanine Positron Emission Tomography
48. The effects of molar activity on [18F]FDOPA uptake in patients with neuroendocrine tumors.
49. Comparative biodistribution analysis across four different Zr-monoclonal antibody tracers-The first step towards an imaging warehouse
50. Reversal of secondary protein-losing enteropathy after surgical revision of a jejunal Roux-en-Y loop in a patient after liver transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.